We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI-Based Tissue Staining Detects Amyloid Deposits Without Chemical Stains or Polarization Microscopy

By LabMedica International staff writers
Posted on 19 Sep 2024
Print article
Image: Virtual birefringence imaging and histological staining of amyloid deposits in label-free tissue (Photo courtesy of Ozcan Research Group)
Image: Virtual birefringence imaging and histological staining of amyloid deposits in label-free tissue (Photo courtesy of Ozcan Research Group)

Systemic amyloidosis, a disorder characterized by the buildup of misfolded proteins in organs and tissues, presents significant diagnostic difficulties. The condition affects millions of people each year, often resulting in severe organ damage, heart failure, and high mortality rates if not diagnosed and treated early. Traditionally, the detection of amyloid deposits has relied on Congo red staining viewed under polarized light microscopy, which has been considered the gold standard. However, this method is time-consuming, costly, and prone to variability that can lead to misdiagnoses. Researchers have now developed a groundbreaking method for imaging and detecting amyloid deposits in tissue samples. This innovative approach uses deep learning and autofluorescence microscopy to create virtual birefringence imaging and histological staining, removing the need for polarization imaging and traditional stains like Congo red.

The new technique, described in Nature Communications and developed by researchers at the University of California, Los Angeles (UCLA, Los Angeles, CA, USA), employs a single neural network to convert autofluorescence images of unstained tissue into high-resolution brightfield and polarized microscopy images. These images resemble those produced by conventional histochemical staining and polarization microscopy. The method was tested on cardiac tissue samples and demonstrated that the virtually stained images consistently and accurately identified amyloid patterns. This approach eliminates the need for chemical staining and specialized polarization microscopes, potentially accelerating diagnosis and lowering costs. The virtual staining process matched and even surpassed the quality of traditional methods, as confirmed by multiple board-certified pathologists from UCLA.

The study’s results indicate that this virtual staining technique could be easily incorporated into current clinical workflows, encouraging wider use of digital pathology. The method does not require specialized optical components and can be deployed on standard digital pathology scanners, making it accessible to a broad range of healthcare facilities. Researchers plan to extend their evaluations to other tissue types, including kidney, liver, and spleen, to further validate the technique's effectiveness across various forms of amyloidosis. They also aim to develop automated detection systems to assist pathologists in identifying problematic regions, potentially enhancing diagnostic accuracy and minimizing false negatives.

“Our deep learning model can perform both autofluorescence-to-birefringence and autofluorescence-to-brightfield image transformations, offering a reliable, consistent, and cost-effective alternative to traditional histology methods. This breakthrough could greatly enhance the speed and accuracy of amyloidosis diagnosis, reducing the risk of false negatives and improving patient outcomes,” said Dr. Aydogan Ozcan, the senior author of the study and the Volgenau Chair for Engineering Innovation at UCLA. “This innovation represents a significant step forward in the field of amyloidosis pathology. It not only simplifies the diagnostic process but also holds potential for expanding the use of digital pathology in routine clinical practice, particularly in resource-limited settings.”

Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
EBV DNA Quantitative Fluorescence Diagnostic Kit
S3015E EBV
New
PoC Testing Device
QuikRead

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: A scanning electron microscope image of chiral gold nanoparticles developed for a new microfluidic chip (Matter, 2024; DOI: 10.1016/j.matt.2024.09.005)

Simple Blood Draw Helps Diagnose Lung Cancer 10 Times Faster

Once dismissed as cellular waste, exosomes—tiny vesicles released by cells containing proteins, DNA, or RNA fragments—have emerged as vital players in cell-to-cell communication over the past decade.... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.